Genetics: In the first years, she underwent different genetic testing (Sanger sequencing) in order to exclude Unverricht–Lundborg disease (cystatin B, CSTB), PME with renal failure (SCARB2), Lafora disease (laforin—EPM2A, and malin—NHLRC1). Here, CSTB is linked to progressive myoclonus epilepsy.